Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $51.00

Posted by George Bondi on Sep 24th, 2026

Guardian Pharmacy Services (NYSE:GRDN – Free Report) had its price target upped by Truist Financial from $47.00 to $51.00 in a research report released on Monday, MarketBeat Ratings reports. They currently have a buy rating on the stock.

Several other brokerages also recently issued reports on GRDN. Weiss Ratings raised shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Bank of America upped their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Oppenheimer increased their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Saturday, September 19th. Nine equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $45.57.

View Our Latest Analysis on Guardian Pharmacy Services

Guardian Pharmacy Services Trading Down 3.3%

Shares of GRDN opened at $43.20 on Monday. The company’s fifty day simple moving average is $40.72 and its 200-day simple moving average is $39.12. The company has a market cap of $2.15 billion, a P/E ratio of 41.94, a P/E/G ratio of 2.31 and a beta of 0.06. Guardian Pharmacy Services has a twelve month low of $23.14 and a twelve month high of $48.33.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. Analysts predict that Guardian Pharmacy Services will post 1.19 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors have recently modified their holdings of GRDN. Arizona State Retirement System raised its stake in shares of Guardian Pharmacy Services by 53.0% during the second quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after acquiring an additional 2,907 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Guardian Pharmacy Services in the second quarter worth approximately $335,000. Round Rock Advisors LLC grew its stake in Guardian Pharmacy Services by 57.0% in the second quarter. Round Rock Advisors LLC now owns 18,524 shares of the company’s stock worth $776,000 after purchasing an additional 6,729 shares in the last quarter. Braun Stacey Associates Inc. purchased a new position in Guardian Pharmacy Services during the 2nd quarter worth $14,234,000. Finally, Ranger Investment Management L.P. purchased a new position in Guardian Pharmacy Services during the 2nd quarter worth $7,263,000.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.